Cargando…

Notes from the Field: Epidemiologic Characteristics of SARS-CoV-2 Recombinant Variant XBB.1.5 — New York City, November 1, 2022–January 4, 2023

Detalles Bibliográficos
Autores principales:	Luoma, Elizabeth, Rohrer, Rebecca, Parton, Hilary, Hughes, Scott, Omoregie, Enoma, Taki, Faten, Wang, Jade C., Akther, Saymon, Amin, Helly, Chang, Carolyn, Cheng, Iris, Di Lonardo, Steve, Eddy, Meredith, Firestein, Lauren, Li, Wenhui, Su, Michelle, Lee, Ellen H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2023
Materias:	Notes from the Field
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949853/ https://www.ncbi.nlm.nih.gov/pubmed/36821721 http://dx.doi.org/10.15585/mmwr.mm7208a4

Ejemplares similares

2304. Surveillance strategies for the detection of new SARS-CoV-2 variants across epidemiological contexts
por: Roster, Kirstin Oliveira, et al.
Publicado: (2023)

No Novel Prevalent Mutations Detected in the Circulating Strains of BF.7, BA.5.2, DY, and XBB — China, November 2022 to June 2023
por: Wang, Liang, et al.
Publicado: (2023)

In the Literature: January 2023
por: Martín-Arana, J., et al.
Publicado: (2023)

January 2023 obituaries
Publicado: (2023)

Inaugural Editorial, January 2023
por: Gaut, Brandon S, et al.
Publicado: (2023)

Editors’ Pick in January 2023
por: Yang, Hee-Jin, et al.
Publicado: (2023)

Study on the COVID-19 epidemic in mainland China between November 2022 and January 2023, with prediction of its tendency
por: Bai, Yao, et al.
Publicado: (2023)

Editors’ Pick in November 2023
por: Chung, Moonyoung
Publicado: (2023)

Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 2022
por: Greene, Sharon K., et al.
Publicado: (2022)

PUBLIC MEETING - January 2023 - Recording
por: Staff Association
Publicado: (2023)

Salary Scale 1 January 2023
por: Stappers, Sara
Publicado: (2023)

Actuarial dashboard as at 1 January 2023
Publicado: (2023)

JHEP at a glance (January 2023)
Publicado: (2023)

Progress report: January - November, 1968
Publicado: (1968)

Coding-Complete Genome Sequences of 40 SARS-CoV-2 Omicron XBB, XBB.1, and XBB.2 Sublineage Strains in Bangladesh
por: Habib, Mohammad Tanbir, et al.
Publicado: (2023)

2023 January issue Journal of Orthopaedic Translation
por: Xiao, Guozhi
Publicado: (2023)

Human vaccines & immunotherapeutics: News January 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

MPS progress report, January - November 1968
por: Rodgers, N
Publicado: (1968)

Coding-complete genomes of XBB.1.16, XBB.2.3, FL.4 (alias of XBB.1.9.1.4), and XBB.3 of SARS-CoV-2 Omicron isolated from Bangladesh
por: Rahman, Saikt, et al.
Publicado: (2023)

BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer
por: Valanparambil, Rajesh M., et al.
Publicado: (2023)

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023
por: Link-Gelles, Ruth, et al.
Publicado: (2023)

In this issue: Volume 114, Issue 1, January 2023
Publicado: (2023)

Prediction and prevention of preeclampsia: Number 1 – January 2023
por: Peixoto-Filho, Fernando Maia, et al.
Publicado: (2023)

Cholera Outbreak — Haiti, September 2022–January 2023
por: Vega Ocasio, Denisse, et al.
Publicado: (2023)

In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1
por: Pochtovyi, Andrei A., et al.
Publicado: (2023)

In this issue: Volume 114, Issue 11, November 2023
Publicado: (2023)

Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023
por: Akash, Shopnil, et al.
Publicado: (2023)

SARS-CoV-2 Variants BQ.1 and XBB.1.5 in Wastewater of Aircraft Flying from China to Denmark, 2023
por: Qvesel, Amanda Gammelby, et al.
Publicado: (2023)

Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 – the public health challenges
por: Velavan, Thirumalaisamy P., et al.
Publicado: (2023)

Rules of the CERN Health Insurance Scheme (as of 1 January 2023)
por: Barbin, Lucie
Publicado: (2022)

Wild poliovirus type 3 (WPV3)-shedding event following detection in environmental surveillance of poliovirus essential facilities, the Netherlands, November 2022 to January 2023
por: Duizer, Erwin, et al.
Publicado: (2023)

Campbell title registrations to date – November 2023, and discontinued protocols
Publicado: (2023)

XBB.1.5 an emerging threat: correspondence
por: Mohanty, Aroop, et al.
Publicado: (2023)

Imprinted hybrid immunity against XBB reinfection
por: Boyton, Rosemary J, et al.
Publicado: (2023)

Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3
por: Faraone, Julia N., et al.
Publicado: (2023)

Evolution of the vls Antigenic Variability Locus of the Lyme Disease Pathogen and Development of Recombinant Monoclonal Antibodies Targeting Conserved VlsE Epitopes
por: Li, Li, et al.
Publicado: (2022)

Anti–SARS-CoV-2 Pharmacotherapies Among Nonhospitalized US Veterans, January 2022 to January 2023
por: Yan, Lei, et al.
Publicado: (2023)

A commentary on ‘Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023’
por: Chiu, Si-Un Frank, et al.
Publicado: (2023)

Progress Toward Poliomyelitis Eradication — Worldwide, January 2021–March 2023
por: Lee, Scarlett E., et al.
Publicado: (2023)

Progress Toward Poliomyelitis Eradication — Pakistan, January 2022–June 2023
por: Mbaeyi, Chukwuma, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p6s3ie37qgi2curbrinooqjcoj